Dummer, Trevor J

Published purpose

The CIHR Institute of Cancer Research (CIHR-ICR) has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation. This PA will fund Breast Cancer research in the following priority areas: • General Breast Cancer Research o research that supports CIHR-ICR’s mandate in the area of Breast Cancer • Breast Cancer Prevention and/or Early Detection of Breast Cancer o research that prevents the onset of breast cancer (lowers cancer risk) and/or reduces the severity of the disease through early detection when it is at its most treatable. • Breast Cancer Survivorship o research that mitigates the challenges experienced along the breast cancer survivorship journey and improves the health outcomes for breast cancer survivors of all ages from the time of their cancer diagnosis until the time of their death or entry into end-of-life care. o specifically in the areas of: ¿ Late & Long-Term Effects ¿ Survivors’ Experiences & Outcomes ¿ Models of Care o This PA will not fund research focused on improving end-of-life care. • This PA supports research that creates new knowledge and/or moves it into practice in the health system, communities, workplaces, and in the daily lives of Canadians.